Physician profile
Danielle Staecker
NPI 1598950768
$555.10
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.73 · 2020: $143 · 2021: $75.45 · 2022: $73.67 · 2023: $168 · 2024: $61.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $200.45 | 2019-2024 | |
| Astellas Pharma US INC | $106.65 | 2023-2024 | Veozah |
| Organogenesis INC. | $56.49 | 2021 | |
| Minerva Surgical, INC | $42.10 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $35.76 | 2023 | Dupixent |
| Medtronic, INC. | $31.57 | 2022 | |
| Gynesonics, INC. | $23.99 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Teleflex LLC | $21.40 | 2023 | Weck |
| Ibsa Pharma INC. | $20.14 | 2024 | Tirosint, Licart |
| Duchesnay USA Incorporated | $16.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Staecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.